Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Sodium Valproate 200mg + Valproic Acid 87mg Tablet
Dosage Form : Tablet
Packaging Type : Alu Strip
Packaging : 10*10
Price : ₹69.55/-
Sodium Valproate 200mg + Valproic Acid 87mg tablet is a broad-spectrum antiepileptic formulation used for the effective management of seizure disorders and epilepsy.
It works by stabilizing neuronal membranes and increasing GABA levels in the brain, thereby preventing abnormal electrical discharges and reducing the frequency and severity of seizures.
This tablet is commonly prescribed for generalized and partial seizures, bipolar disorder management, and migraine prophylaxis, providing comprehensive neurological support.
With strong clinical efficacy, proven safety profile, and high prescription acceptance, this formulation enhances a neurology-focused product range and supports consistent therapeutic demand.
Common side effects may include nausea, vomiting, dizziness, tremors, weight gain, or mild gastrointestinal discomfort. Rarely, liver dysfunction or thrombocytopenia may occur; regular monitoring is advised.
Valpotime CR 300 Tablet is indicated for the management of epilepsy, including generalized and partial seizures, bipolar disorder, and migraine prophylaxis, as prescribed by a healthcare professional.
For oral use only. Use strictly under medical supervision. Do not discontinue abruptly without consulting a physician. Inform your doctor of any liver, kidney, or metabolic disorders prior to use.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.
Composition : Calcium Dobesilate Monohydrate I.P. 0.5% w/w + Lignocaine Hydrochloride I.P. 3% w/w + Hydrocortisone Acetate I.P. 0.25% w/w + Zinc Oxide I.P. 5% w/w
Composition : Chlorhexidine Gluconate (0.20% w/w) + Silver Nitrate (0.20% w/w) cream
Composition : Silver Sulfadiazine (1%) + Chlorhexidine Gluconate (0.2%) + Metronidazole (1%) Cream
Composition : Clindamycin (1% w/w)Gel
Composition : Clindamycin 1 % w/w + Niacinamide 4 % w/w Gel
Composition : Clobetasol Propionate I.P. 0.05%w/w
Composition : Beclometasone (0.025% w/v) + Clotrimazole (1% w/v) lotion
Composition : Ofloxacin I.P. 0.75% w/w + Ornidazole I.P. 2.0% w/w + Itraconazole B.P. 1.0% w/w + Clobetasol Propionate I.P. 0.05% w/w + Methylparaben I.P. 0.2% w/w + Propylparaben I.P. 0.02% w/w Cream
Composition : Metronidazole (1% w/w) + Sucralfate (7% w/w) + Povidone Iodine (5% w/w)
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our Successful network today.
Quick Navigation
1500+ Products
Our Divisions
All Therapeutics
Disclaimer: Pharma Insights are based on operational standards as of March 2026. All territories are subject to availability and Revised Schedule M compliance.